An investigation on behalf of investors in Valeritas Holdings, Inc. (NASDAQ:VLRX) shares over potential wrongdoing at Valeritas Holdings, Inc. was announced and NASDAQ:VLRX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 08/11/2017 -- An investigation on behalf of investors in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) was announced over potential breaches of fiduciary duties by certain directors at Valeritas Holdings.
Investors who purchased shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) and currently hold any of those NASDAQ:VLRX shares have certain options and should contact the Shareholders Foundation at email@example.com or call 858-779-1554.
The investigation by a law firm concerns whether certain Valeritas Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders.
Bridgewater, NJ based Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. Valeritas Holdings, Inc. reported that its annual Total Revenue rose from $18.10 million in 2015 to $19.55 million in 2016 and that its Net loss declined from $67.19 million in 2015 to $46.37 million in 2016.
Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) closed on August 10, 2017 at $5.64 per share.
Those who purchased shares of Valeritas Holdings, Inc. (NASDAQ:VLRX), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels